(Q36677627)

15 August 2017

1 reference

title

On-demand therapy for gastroesophageal reflux disease (English)

1 reference

gastroesophageal reflux disease

15 August 2017

main subject

0 references

2

John M Inadomi

1 reference

15 August 2017

David C Metz

1

1 reference

15 August 2017

Colin W Howden

series ordinal

3

1 reference

15 August 2017

Sander J Veldhuyzen van Zanten

series ordinal

4

1 reference

15 August 2017

Peter Bytzer

series ordinal

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

The American Journal of Gastroenterology

15 August 2017

published in

1 reference

15 August 2017

volume

102

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

642-653

1 reference

The burden of selected digestive diseases in the United States.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Economic evaluation of long-term management strategies for erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastro-oesophageal reflux symptoms in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general med

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Review article: the clinical pharmacology of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Review article: immediate-release proton-pump inhibitor therapy--potential advantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

The rise and rise of proton pump inhibitor drugs: Patients' perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00998.X

10.1111/J.1572-0241.2006.00998.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference